HAO (Haoxi Health Technology) ROCE %: -76.80% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HAO Haoxi Health Technology Ltd HAO
21 GF Score
Price $3.84
! 5 Warning Signs
View Full Analysis

What is Haoxi Health Technology ROCE %?

Haoxi Health Technology HAO -13.51% 21 ROCE % is -76.80% as of Dec. 2025. GuruFocus rates HAO with a GF Score™ of 21/100. The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Haoxi Health Technology's annualized ROCE % for the quarter that ended in Dec. 2025 was -76.80%.

Haoxi Health Technology  (NAS:HAO) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Haoxi Health Technology ROCE % Related Terms

Haoxi Health Technology ROCE % Historical Data

* Premium members only.

The historical data trend for Haoxi Health Technology's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Haoxi Health Technology ROCE % Chart

Haoxi Health Technology Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
ROCE %
239.86 0.00 575.30 26.26 28.57

Haoxi Health Technology Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only 83.07 28.03 0.33 45.70 -76.80
HAO
21GF Score
Haoxi Health Technology Ltd HAO
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Haoxi Health Technology ROCE % Calculation

Haoxi Health Technology's annualized ROCE % for the fiscal year that ended in Jun. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=4.193/( ( (15.507 - 3.867) + (21.595 - 3.885) )/ 2 )
=4.193/( (11.64+17.71)/ 2 )
=4.193/14.675
=28.57 %

Haoxi Health Technology's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=-13.03/( ( (21.595 - 3.885) + (20.661 - 4.438) )/ 2 )
=-13.03/( ( 17.71 + 16.223 )/ 2 )
=-13.03/16.9665
=-76.80 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -76.80% mean?
Haoxi Health Technology (HAO) has a ROCE % of -76.80% as of Dec. 2025.
Is Haoxi Health Technology's ROCE % too high?
Haoxi Health Technology's current ROCE % is -76.80%. Overall, Haoxi Health Technology has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Haoxi Health Technology's ROCE % compare to BAOS and DBMM?
Haoxi Health Technology's ROCE % of -76.80% can be compared against companies in the Media - Diversified industry. The industry median ROCE % is 3.28. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Media - Diversified company?
The median ROCE % among Media - Diversified companies is 3.28, based on 975 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Media - Diversified industry, the median ROCE % is 3.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Haoxi Health Technology's current ROCE % is -76.80%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haoxi Health Technology stock overvalued right now?
Haoxi Health Technology (HAO) has a current ROCE % of -76.80%. The current ROCE % is -76.80%. Haoxi Health Technology's overall GF Score™ is 21/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Haoxi Health Technology (HAO), the current ROCE % is -76.80% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Haoxi Health Technology Business Description

Address Room 801, Tower C, Floor 8, Building 103, Huizhongli, Chaoyang District, Beijing, CHN
Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. The company offers services that include planning, producing, placing, and optimizing online ads especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms. It places advertisements on popular digital platforms such as Toutiao, Douyin, WeChat, and Sina Weibo through media partners. Revenue is generated by providing comprehensive online marketing solutions. The company's operations center on digital advertising via mainstream video and social media channels in the Chinese market.
21GF Score

Get the complete analysis for HAO

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.84
Price